Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review

Table 3 Outcome indicators employed in the literature to assess clinical inertia

	References
Percentage of patients with HbA1c < 7%	[83]
Time required to reach targets of HbA1c, sBP and LDL cholesterol	[87]
Comparison between personalized HbA1c target and actual HbA1c levels	[73]
Percentage of patients who do not achieve the individualized targets	[90]
Life expectancy and economic burden associated with diabetes-related complications in populations reaching different targets of HbA1c, in a series of models of delayed therapy intensification e and across a range of time horizons	[91]
Median time to the progression of diabetic retinopathy	[92]
Incidence rate of diabetic retinopathy progression in presence or absence of clinical inertia (lack of initiation of insulin therapy within 3 months from a report of HBA1c > 9%)	[92]

ISSN: 1758-5996